Component
Delta1-piperideine-6-carboxylate
Independent small molecule record; interpretation is limited by each linked claim and its study context.
7 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
P6C reacts with PLP to form a Knoevenagel condensation product that inactivates the cofactor.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Direct lysine-metabolite to vitamin-B6 antagonism.
- experimental_model
- Affected children, expressed human ALDH7A1 variants and metabolite chemistry
- exposure
- Biochemical P6C-PLP reaction.
- limitations
- Direct chemistry supports sequestration; it does not quantify PLP loss in every neuronal compartment.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- The accumulated lysine metabolite chemically traps activated B6.
- primary_references
- [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
- tissue_or_cell_type
- Cell-free chemistry
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1171–1182
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Affected children, expressed human ALDH7A1 variants and metabolite chemistry · source_derived_draft · unverified_draft
### b6-neuro-p6c-plp-sequestration P6C reacts with PLP to form a Knoevenagel condensation product that inactivates the cofactor. Condition category: machinery_impairment nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The accumulated lysine metabolite chemically traps activated B6. organism: Homo sapiens tissue_or_cell_type: Cell-free chemistry experimental_model: Affected children, expressed human ALDH7A1 variants and metabolite chemistry limitations: Direct chemistry supports sequestration; it does not quantify PLP loss in every neuronal compartment. exposure: Biochemical P6C-PLP reaction. cross_nutrient: Direct lysine-metabolite to vitamin-B6 antagonism. [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
Complete structured claim and evidenceP6C and acetoacetate form 2-OPP in chemical incubations including plasma.
Experimental context and source evidence
- affected_machinery
- ALDH7A1
- availability_state
- machinery_impairment Imported condition classification; unverified.
- deficiency_not_equivalent
- Dietary lysine deficiency
- experimental_model
- Chemical incubations in aqueous solutions and human biological matrices
- limitations
- In-vivo formation is inferred; patient flux was not measured.
- organism
- Homo sapiens
- plain_language
- An accumulated intermediate can react with a ketone body.
- primary_references
- [engelke2021] Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy (2021). https://www.jci.org/articles/view/148272 DOI: 10.1172/JCI148272
- tissue_or_cell_type
- Body-fluid reaction model
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 302–312
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Chemical incubations in aqueous solutions and human biological matrices · source_derived_draft · unverified_draft
### p6c-acetoacetate-2opp P6C and acetoacetate form 2-OPP in chemical incubations including plasma. Plain language: An accumulated intermediate can react with a ketone body. Condition category: machinery_impairment organism: Homo sapiens tissue_or_cell_type: Body-fluid reaction model experimental_model: Chemical incubations in aqueous solutions and human biological matrices limitations: In-vivo formation is inferred; patient flux was not measured. affected_machinery: ALDH7A1 deficiency_not_equivalent: Dietary lysine deficiency [engelke2021] Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy (2021). https://www.jci.org/articles/view/148272 DOI: 10.1172/JCI148272
Complete structured claim and evidenceAccumulated P6C reacts with PLP through Knoevenagel condensation, reducing cofactor availability.
Experimental context and source evidence
- affected_machinery
- ALDH7A1 upstream clearance
- availability_state
- machinery_impairment Imported condition classification; unverified.
- deficiency_not_equivalent
- Dietary lysine or vitamin B6 deficiency
- experimental_model
- Chemical mechanism associated with human ALDH7A1 disease
- limitations
- Secondary cofactor loss does not demonstrate primary dietary vitamin B6 or lysine deficiency.
- organism
- Homo sapiens
- plain_language
- A lysine metabolite can trap active vitamin B6.
- primary_references
- [mills2006] Mutations in antiquitin in individuals with pyridoxine-dependent seizures. (2006). https://pubmed.ncbi.nlm.nih.gov/16491085/ DOI: 10.1038/nm1366
- tissue_or_cell_type
- PDE-ALDH7A1 biochemical context
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 266–276
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Chemical mechanism associated with human ALDH7A1 disease · source_derived_draft · unverified_draft
### p6c-plp-trapping Accumulated P6C reacts with PLP through Knoevenagel condensation, reducing cofactor availability. Plain language: A lysine metabolite can trap active vitamin B6. Condition category: machinery_impairment organism: Homo sapiens tissue_or_cell_type: PDE-ALDH7A1 biochemical context experimental_model: Chemical mechanism associated with human ALDH7A1 disease limitations: Secondary cofactor loss does not demonstrate primary dietary vitamin B6 or lysine deficiency. affected_machinery: ALDH7A1 upstream clearance deficiency_not_equivalent: Dietary lysine or vitamin B6 deficiency [mills2006] Mutations in antiquitin in individuals with pyridoxine-dependent seizures. (2006). https://pubmed.ncbi.nlm.nih.gov/16491085/ DOI: 10.1038/nm1366
Complete structured claim and evidence
What acts on it
The antiquitin defect was linked to accumulation of alpha-AASA/P6C in the lysine degradation pathway.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Lysine catabolism generates the metabolite that can sequester PLP.
- experimental_model
- Affected children, expressed human ALDH7A1 variants and metabolite chemistry
- exposure
- ALDH7A1-associated disease and metabolite analysis.
- limitations
- This is inherited pathway failure, not lysine toxicity in healthy people.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- A blocked lysine pathway builds up B6-reactive metabolites.
- primary_references
- [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
- tissue_or_cell_type
- Patient biological samples and biochemical pathway analysis
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1158–1169
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Affected children, expressed human ALDH7A1 variants and metabolite chemistry · source_derived_draft · unverified_draft
### b6-neuro-aldh7a1-metabolite-accumulation The antiquitin defect was linked to accumulation of alpha-AASA/P6C in the lysine degradation pathway. Condition category: machinery_impairment nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A blocked lysine pathway builds up B6-reactive metabolites. organism: Homo sapiens tissue_or_cell_type: Patient biological samples and biochemical pathway analysis experimental_model: Affected children, expressed human ALDH7A1 variants and metabolite chemistry limitations: This is inherited pathway failure, not lysine toxicity in healthy people. exposure: ALDH7A1-associated disease and metabolite analysis. cross_nutrient: Lysine catabolism generates the metabolite that can sequester PLP. [mills-2006-aldh7a1] Mutations in antiquitin in individuals with pyridoxine-dependent seizures (2006). https://doi.org/10.1038/nm1366 DOI: 10.1038/nm1366
Complete structured claim and evidenceAlpha-aminoadipate semialdehyde interconverts with its cyclic Schiff base P6C.
Experimental context and source evidence
- experimental_model
- Biochemical characterization
- limitations
- The two chemical species are separate entities connected by equilibrium.
- organism
- Homo sapiens
- plain_language
- One intermediate exists in open-chain and ring forms.
- primary_references
- [mills2006] Mutations in antiquitin in individuals with pyridoxine-dependent seizures. (2006). https://pubmed.ncbi.nlm.nih.gov/16491085/ DOI: 10.1038/nm1366
- tissue_or_cell_type
- Lysine-catabolizing compartments and body fluids
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 94–102
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Biochemical characterization · source_derived_draft · unverified_draft
### aasa-p6c-equilibrium Alpha-aminoadipate semialdehyde interconverts with its cyclic Schiff base P6C. Plain language: One intermediate exists in open-chain and ring forms. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Lysine-catabolizing compartments and body fluids experimental_model: Biochemical characterization limitations: The two chemical species are separate entities connected by equilibrium. [mills2006] Mutations in antiquitin in individuals with pyridoxine-dependent seizures. (2006). https://pubmed.ncbi.nlm.nih.gov/16491085/ DOI: 10.1038/nm1366
Complete structured claim and evidenceHuman peroxisomal PIPOX oxidizes L-pipecolate to P6C.
Experimental context and source evidence
- experimental_model
- Human cDNA cloning and expressed enzyme
- limitations
- Enzyme capability does not establish that this route predominates in human brain; see conflict.
- organism
- Homo sapiens
- plain_language
- Pipecolate can join the common lysine breakdown route.
- primary_references
- [ijlst2000] Molecular cloning and expression of human L-pipecolate oxidase (2000). https://pubmed.ncbi.nlm.nih.gov/10772957/ DOI: 10.1006/bbrc.2000.2575
- tissue_or_cell_type
- Peroxisomes
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 146–154
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human cDNA cloning and expressed enzyme · source_derived_draft · unverified_draft
### pipox-pipecolate-oxidation Human peroxisomal PIPOX oxidizes L-pipecolate to P6C. Plain language: Pipecolate can join the common lysine breakdown route. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Peroxisomes experimental_model: Human cDNA cloning and expressed enzyme limitations: Enzyme capability does not establish that this route predominates in human brain; see conflict. [ijlst2000] Molecular cloning and expression of human L-pipecolate oxidase (2000). https://pubmed.ncbi.nlm.nih.gov/10772957/ DOI: 10.1006/bbrc.2000.2575
Complete structured claim and evidence
Where it participates (unsigned role)
ALDH7A1 deficiency reduces aldehyde clearance, increasing AASA and its equilibrium partner P6C.
Experimental context and source evidence
- affected_machinery
- ALDH7A1
- availability_state
- machinery_impairment Imported condition classification; unverified.
- deficiency_not_equivalent
- Dietary lysine deficiency
- experimental_model
- Human patient biochemical and genetic evidence
- limitations
- Inherited enzyme failure is distinct from inadequate lysine intake.
- organism
- Homo sapiens
- plain_language
- An enzyme block allows reactive lysine metabolites to accumulate.
- primary_references
- [mills2006] Mutations in antiquitin in individuals with pyridoxine-dependent seizures. (2006). https://pubmed.ncbi.nlm.nih.gov/16491085/ DOI: 10.1038/nm1366
- tissue_or_cell_type
- Affected tissues and body fluids
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 254–264
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human patient biochemical and genetic evidence · source_derived_draft · unverified_draft
### aldh7a1-metabolite-accumulation ALDH7A1 deficiency reduces aldehyde clearance, increasing AASA and its equilibrium partner P6C. Plain language: An enzyme block allows reactive lysine metabolites to accumulate. Condition category: machinery_impairment organism: Homo sapiens tissue_or_cell_type: Affected tissues and body fluids experimental_model: Human patient biochemical and genetic evidence limitations: Inherited enzyme failure is distinct from inadequate lysine intake. affected_machinery: ALDH7A1 deficiency_not_equivalent: Dietary lysine deficiency [mills2006] Mutations in antiquitin in individuals with pyridoxine-dependent seizures. (2006). https://pubmed.ncbi.nlm.nih.gov/16491085/ DOI: 10.1038/nm1366
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.